Cuprina Holdings (Cayman) Limited — Company profile
Healthcare · Medical Instruments & Supplies · Singapore
Last price 1.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Details
| Name | Cuprina Holdings (Cayman) Limited |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 10 |
| Founded | 2019 |
| Ipo Date | 2025-04-10 |
| Ceo | Yong Qi Quek |
| Country | Singapore |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | SGD |
| Ipo Price | 4.00 |
| Isin | KYG2592E1109 |
| Cusip | G2592E110 |
| Cik | 1995704 |
| Sic | 3842 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Yong Qi Quek | Chief Executive Officer and Director |
| Tat Jing Chan | Chief Financial Officer |
| Dr. Ronald Sherman | Medical and Scientific Director |
Contact
| Address | Blk 1090, Lower Delta Road #06-08, Singapore, 169201, Singapore |
| Phone | 65 8512 7275 |
| Website | https://www.cuprina.com.sg |